Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively 2022-03-23 06:53
WuXi Biologics Achieved Record Growth and Profitability in 2021 2022-03-23 00:38
INDICAID COVID-19 Rapid Antigen At-Home Test Receives FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non- Prescription Use 2022-03-23 00:00
Jacobio Announces Annual Results of 2021, R&D Investment Increases 83% 2022-03-22 22:50
IFF to Showcase Renewable Industrial Solutions and Polymer Portfolio at American Coatings Show 2022-03-22 21:00
NIBIOHN Identifies Tissue-specific Exosome Marker Candidates from Blood 2022-03-22 14:00
OBiO Technology Goes Public on Shanghai Stock Exchange Today 2022-03-22 13:00
INTERVAPOR®, THERMAL VAPOR TREATMENT SYSTEM, APPROVED FOR MARKETING IN CHINA 2022-03-22 10:34
Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Rare Pediatric Disease Designation by the US FDA for the Treatment of Neuroblastoma 2022-03-22 09:15
Transnetyx Announces Acquisition of a-tune 2022-03-22 04:30
Cali Biosciences Announces Successful Results in Phase IIb Study of Long-Acting Ropivacaine (CPL-01) for Non-Opioid Treatment of Post-Operative Pain 2022-03-22 00:00
Ascentage Pharma Announces 2021 Annual Results with Commercialization Programs Going Full Steam Ahead 2022-03-21 23:11
BIOKANGTAI Signs a Cooperation Agreement with the Largest Importer of Parenteral Products in Philippines 2022-03-21 22:22
3billion to reveal its diagnostic performance at ACMG annual meeting 2022 2022-03-21 22:00
ABclonal Technology Joins YCharOS Industry Advisory Committee to Tackle Reproducibility Crisis in Biomedical Research 2022-03-21 20:15
KAZIA TO PRESENT AT UPCOMING INVESTOR CONFERENCE AND AACR ANNUAL SCIENTIFIC MEETING 2022-03-21 20:00
RNAGENE Signs a Collaborative Research Agreement with PharmAbcine to Develop Novel mRNA Therapeutics 2022-03-21 20:00
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets 2022-03-21 16:20
Genscript Biotech Reports 2021 Annual Results 2022-03-20 22:47
I-Mab to Report Full Year 2021 Financial Results and Provide Corporate Update on March 29, 2022 2022-03-18 20:00
1 168 169 170 171 172 801